한글목차

첨단 약물전달 시스템 시장(2024-2028년)

첨단 약물전달 시스템 시장은 2023-2028년 2,256억 달러 규모로 확대될 것으로 예상되며, 예측 기간 동안 13.3%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 첨단 약물전달 시스템 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 만성질환의 증가, 약물전달에 대한 R&D 투자 증가, 세계 의료비 증가가 시장을 주도하고 있습니다.

이 보고서는 나노기술의 발전이 향후 몇 년 동안 첨단 약물전달 시스템 시장 성장을 주도할 주요 요인 중 하나라고 분석했습니다. 또한, 자가 투여 장치의 부상과 생물학적 제제 및 바이오시밀러 개발의 발전은 시장의 큰 수요를 창출할 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio에 의한 분석

• 가격 민감도·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제5장 시장 규모 실적

• 첨단 약물전달 시스템 세계 시장(2018-2022년)
• 종류별 분석(2018-2022년)
• 지역별 분석(2018-2022년)
• 국가별 분석(2018-2022년)

제6장 정성 분석

• AI의 영향 : 첨단 약물전달 시스템 세계 시장

제7장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제8장 시장 세분화 : 종류별

• 시장 부문
• 비교 : 종류별
• 경구 : 시장 규모와 예측(2023-2028년)
• 주사·흡입 : 시장 규모와 예측(2023-2028년)
• 경피 : 시장 규모와 예측(2023-2028년)
• 담체 기반 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 종류별

제9장 고객 상황

• 고객 상황 개요

제10장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 브라질 : 시장 규모와 예측(2023-2028년)
• 프랑스 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 인도 : 시장 규모와 예측(2023-2028년)
• 사우디아라비아 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제11장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제12장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제13장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Alkermes Public Ltd. Co.
• Antares Pharma Inc.
• Baxter International Inc.
• Becton Dickinson and Co.
• Endo International Plc
• NanoPass Technologies Ltd.
• Nektar Therapeutics
• Perrigo Co. Plc
• Teva Pharmaceutical Industries Ltd.

제14장 부록

영문목차

Advanced Drug Delivery Systems Market 2024-2028

The advanced drug delivery systems market is forecasted to grow by USD 225.6 bn during 2023-2028, accelerating at a CAGR of 13.3% during the forecast period. The report on the advanced drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising chronic disease, rising investment in research and development of drug delivery, and rising healthcare expenditure globally.

Technavio's advanced drug delivery systems market is segmented as below:

By Type

• Oral
• Injection and inhalation
• Transdermal
• Carrier-based
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancements in nanotechnology as one of the prime reasons driving the advanced drug delivery systems market growth during the next few years. Also, rise of self-administration devices and growing development of biologics and biosimilars will lead to sizable demand in the market.

The report on the advanced drug delivery systems market covers the following areas:

• Advanced Drug Delivery Systems Market sizing
• Advanced Drug Delivery Systems Market forecast
• Advanced Drug Delivery Systems Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading advanced drug delivery systems market vendors that include 3M Co., Alfresa Holdings Corp., Alkermes Public Ltd. Co., AmerisourceBergen Corp., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Co., Cardinal Health Inc., Endo International Plc, J M Smith Corp., NanoPass Technologies Ltd., Nektar Therapeutics, Perrigo Co. Plc, Philip Morris International Inc., Prodigy Health, Surmodics Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Ypsomed Holding AG. Also, the advanced drug delivery systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Advanced Drug Delivery Systems Market 2018 - 2022
  • Historic Market Size - Data Table on Global Advanced Drug Delivery Systems Market 2018 - 2022 ($ billion)
• 5.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 5.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 5.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Advanced Drug Delivery Systems Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

• 8.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 8.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 8.3 Oral - Market size and forecast 2023-2028
  • Chart on Oral - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
  • Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Data Table on Oral - Year-over-year growth 2023-2028 (%)
• 8.4 Injection and inhalation - Market size and forecast 2023-2028
  • Chart on Injection and inhalation - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Injection and inhalation - Market size and forecast 2023-2028 ($ billion)
  • Chart on Injection and inhalation - Year-over-year growth 2023-2028 (%)
  • Data Table on Injection and inhalation - Year-over-year growth 2023-2028 (%)
• 8.5 Transdermal - Market size and forecast 2023-2028
  • Chart on Transdermal - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Transdermal - Market size and forecast 2023-2028 ($ billion)
  • Chart on Transdermal - Year-over-year growth 2023-2028 (%)
  • Data Table on Transdermal - Year-over-year growth 2023-2028 (%)
• 8.6 Carrier-based - Market size and forecast 2023-2028
  • Chart on Carrier-based - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Carrier-based - Market size and forecast 2023-2028 ($ billion)
  • Chart on Carrier-based - Year-over-year growth 2023-2028 (%)
  • Data Table on Carrier-based - Year-over-year growth 2023-2028 (%)
• 8.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 8.8 Market opportunity by Type
  • Market opportunity by Type ($ billion)
  • Data Table on Market opportunity by Type ($ billion)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 10.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 10.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 10.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 10.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 10.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 10.9 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 10.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 10.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 10.12 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 10.13 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ billion)
  • Data Table on France - Market size and forecast 2023-2028 ($ billion)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 10.14 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 10.15 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 10.16 Saudi Arabia - Market size and forecast 2023-2028
  • Chart on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Saudi Arabia - Year-over-year growth 2023-2028 (%)
  • Data Table on Saudi Arabia - Year-over-year growth 2023-2028 (%)
• 10.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers
• 11.2 Market challenges
• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview
• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 12.3 Landscape disruption
  • Overview on factors of disruption
• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered
• 13.2 Company ranking index
  • Company ranking index
• 13.3 Market positioning of companies
  • Matrix on companies position and classification
  • 3M Co.
  • 3M Co. - Overview
  • 3M Co. - Business segments
  • 3M Co. - Key news
  • 3M Co. - Key offerings
  • 3M Co. - Segment focus
  • SWOT
• 13.5 Alkermes Public Ltd. Co.
  • Alkermes Public Ltd. Co. - Overview
  • Alkermes Public Ltd. Co. - Product / Service
  • Alkermes Public Ltd. Co. - Key offerings
  • SWOT
• 13.6 Antares Pharma Inc.
  • Antares Pharma Inc. - Overview
  • Antares Pharma Inc. - Product / Service
  • Antares Pharma Inc. - Key offerings
  • SWOT
• 13.7 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 13.8 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 13.9 Endo International Plc
  • Endo International Plc - Overview
  • Endo International Plc - Business segments
  • Endo International Plc - Key news
  • Endo International Plc - Key offerings
  • Endo International Plc - Segment focus
  • SWOT
• 13.10 NanoPass Technologies Ltd.
  • NanoPass Technologies Ltd. - Overview
  • NanoPass Technologies Ltd. - Product / Service
  • NanoPass Technologies Ltd. - Key offerings
  • SWOT
• 13.11 Nektar Therapeutics
  • Nektar Therapeutics - Overview
  • Nektar Therapeutics - Product / Service
  • Nektar Therapeutics - Key offerings
  • SWOT
• 13.12 Perrigo Co. Plc
  • Perrigo Co. Plc - Overview
  • Perrigo Co. Plc - Business segments
  • Perrigo Co. Plc - Key offerings
  • Perrigo Co. Plc - Segment focus
  • SWOT
• 13.13 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT

14 Appendix

• 14.1 Scope of the report
• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 14.4 Research methodology
  • Research methodology
• 14.5 Data procurement
  • Information sources
• 14.6 Data validation
  • Data validation
• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 14.8 Data synthesis
  • Data synthesis
• 14.9 360 degree market analysis
  • 360 degree market analysis
• 14.10 List of abbreviations
  • List of abbreviations